955979-13-2

Basic information

• Product Name: 4-(2-hydroxy-ethyl)-3-oxo-piperazine-1-carboxylic acid benzyl ester
• Synonyms: 4-(2-hydroxy-ethyl)-3-oxo-piperazine-1-carboxylic acid benzyl ester
• CAS NO: 955979-13-2
• Molecular Weight: 278.308
• Mol File: 955979-13-2.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 4-(2-hydroxy-ethyl)-3-oxo-piperazine-1-carboxylic acid benzyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-hydroxy-ethyl)-3-oxo-piperazine-1-carboxylic acid benzyl ester(955979-13-2)
• EPA Substance Registry System: 4-(2-hydroxy-ethyl)-3-oxo-piperazine-1-carboxylic acid benzyl ester(955979-13-2)

Safety Data

• Hazardous Substances Data: 955979-13-2(Hazardous Substances Data)

Upstream product

• 75-21-8 oxirane 
• 78818-15-2 4-benzyloxycarbonylpiperazin-2-one 
• 17739-45-6 2-(2-bromoethoxy)tetrahydropyran 
• 885698-74-8 4-(2-acetoxy-ethyl)-3-oxo-piperazine-1-carboxylic acid benzyl ester 

Downstream Products

• 1590411-01-0 C₃₂H₂₇F₄N₃O₆ 
• 1590403-75-0 C₂₄H₂₁F₄N₃O₄ 
• 1429471-48-6 C₁₄H₁₆N₂O₄ 
• 234108-65-7 4-(benzyloxycarbonyl)-1-(2-iodoethyl)-piperazin-2-one 

Relevant articles and documents

ANTI-FIBROTIC PYRIDINONES

This application relates to polycyclic compounds with a pyridinone or pyridinone derivative core including, substituted pyridinones, 5,6- and 6,6- bicyclic heterocycles and substituted pyridine-thiones. This application also discloses methods of preparing these polycyclic compounds, pharmaceutical compositions and medicaments comprising said compounds and methods to treat, prevent or diagnose diseases, disorders or conditions associated with fibrosis.

PYRIMIDINE DERIVATIVES AS PI3K INHIBITORS

Thienopyrimidines of formula (Ia) or (Ib): wherein R1, R2, R3, are as defined in the claims.

Novel nitropyrazinyl- and nitropyridinyl- substituted piperazin-3-one and hexahydro-1H-1,4-diazepin-5-one compounds useful as adjuncts to radiation therapy

Novel nitropyrazinyl- and nitropyridinyl- substituted piperazin-3-one and hexahydro-1H-1,4-diazepin-5-one compounds are disclosed to have activity in increasing the sensitivity of hypoxic tumor cells to radiation. Also disclosed are methods of preparing s